Prostate Cancer - Results from #25580

Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer - Abstract June 20, 2012

Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy - Abstract June 20, 2012

Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification me June 20, 2012

Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: A population-based study - Abstract June 20, 2012

Long-term outcomes of the FRESH START trial: Exploring the role of self-efficacy in cancer survivors' maintenance of dietary practices and physical activity - Abstract June 20, 2012

Understanding the psychosocial issues of African American couples surviving prostate cancer - Abstract June 20, 2012

Janssen submits additional marketing applications for ZYTIGA® in the U.S. and European Union June 20, 2012

Predicting prostate biopsy outcome: Prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers - Abstract June 19, 2012

The role of distal third radius dual energy X-ray absorptiometry (DXA) and central DXA in evaluating for osteopenia and osteoporosis in men receiving androgen deprivation therapy for prostate cancer - Abstract June 19, 2012

Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancer - Abstract June 19, 2012

Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer - Abstract June 19, 2012

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial - Abstract June 19, 2012

Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer - Abstract June 19, 2012

The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: Results from the Gothenburg Randomized Screening Trial - Abstract June 19, 2012

Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy - Abstract June 19, 2012

Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer - Abstract June 19, 2012

Prostate cancer and occupational whole-body vibration exposure - Abstract June 19, 2012

BJUI Mini Reviews - Quality-of-care framework in urological cancers: Where do we stand? June 19, 2012

The impact of multiple biopsies on outcomes of nerve-sparing robotic-assisted radical prostatectomy - Abstract June 18, 2012

Clinical development of novel therapeutics for castration-resistant prostate cancer: Historic challenges and recent successes - Abstract June 18, 2012

Page 1280 of 1436